Marc Cluzel
Independent Director
Moleac Pte Ltd
Singapore
Biography
Marc Cluzel M.D., Ph.D. got his degrees from the University of Montpellier, in France. He started as the Assistant Professor at Montpellier Hospital then continued to become the visiting Assistant Professor for 3 years at Johns Hopkins University before moving to Guy’s Hospital London as Research Associate in 1990. In 1991 he joined Sanofi as a clinical pharmacologist where he moved up to become Head of Sanofi R&D in January 2007. From 1996 to 2006 Marc chaired the development operational committee and was involved in decisions on more than hundreds of compounds. He actively participated in the life management of Plavix, Aprovel and Taxotere and registration of Fasturtec, Eloxatin, Arixtra, Uro-Xatral, Ambien CR, Multaq and Jevtana, in the US. In January 2011 he founded C&F consulting and since May 2012 he is a board member at Morphosys’s. Marc advises Moleac on various issues, including R & D and Clinical Research.
Research Interest
Phamacology
